Skip to content

Resources

See how ARCEX
Therapy works

ARCEX Resources

Instructions for Use (IFU)

Frequently Asked Questions (FAQs)

US Clinics offering ARCEX

Read our Publications

    Learn more

    Please complete this form to contact us or receive updates

    Complete form

    Resources from our Community Partners

    Christopher & Dana Reeve Foundation

    Peer-to-peer mentors, military & Veterans program, virtual support groups, and more

    Help Hope Live

    Medical fundraising website

    US Department of Veterans Affairs

    System of care for spinal cord injuries and disorders

    Wings for Life

    Helpful resources for those affected, relatives, and general practitioners

    Fördergemeinschaft der Querschnittgelähmten (FGQ)

    Helpful resources for those affected, relatives, and general practitioners

    Spinal Research

    Facebook page that explains and discusses the latest research

    UW Medicine

    Educational resources from the University of Washington

    Model Systems Knowledge Translation Center

    Fact sheets on more than 25 topics for living with SCI

    Praxis

    A resource for Canadians discussing a community advocacy initiative

    Swiss Paraplegic Group

    Counseling and support for day-to-day life

    Explore our Blog

      Read more

      Find the answers to
      Frequently Asked Questions

      Go to FAQs
      The ONWARD® Medical ARCEX® System is FDA cleared for use in the United States and CE marked in accordance with EU Medical Device Regulation 2017/745. ONWARD ARCIM® and ARCBCI™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.

      *Indication for Use (US): The ARCEX® System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old who present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).

      *Indication for Use (EU): The ARCEX® System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic and with take-home exercises in the home to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive).